CN Patent

CN104080794B — RNAi试剂、组合物及其用于治疗甲状腺素运载蛋白(TTR)相关疾病的使用方法

Assigned to Alnylam Pharmaceuticals Inc · Expires 2018-03-16 · 8y expired

What this patent protects

本发明提供了靶向甲状腺素运载蛋白(TTR)基因的RNAi试剂(例如双链RNAi试剂)和使用这样的RNAi试剂用于治疗或预防TTR相关疾病的方法。

USPTO Abstract

本发明提供了靶向甲状腺素运载蛋白(TTR)基因的RNAi试剂(例如双链RNAi试剂)和使用这样的RNAi试剂用于治疗或预防TTR相关疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN104080794B
Jurisdiction
CN
Classification
—
Expires
2018-03-16
Drug substance claim
No
Drug product claim
No
Assignee
Alnylam Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.